Skip to main content
SpringerLink
Log in

Glucagon in Cirrhosis of the Liver

  • Chapter
Glucagon II

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 66 / 2))

  • 158 Accesses

Abstract

In patients with cirrhosis of the liver, a high frequency of abnormal carbohydrate tolerance, along with a state of insulin resistance, has been demonstrated (CreutzFeldt et al. 1970). The cause of these alterations is unknown, and the possible implication of elevated circulating growth hormone (Conn and Daughaday 1970), potassium depletion (Podolsky et al. 1973), and increased plasma levels of free fatty acids (Felber et al. 1967) has been considered.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aguilar-Parada E, Eisentraut AM, Unger RH (1969) Pancreatic glucagon secretion in normal and diabetic subjects. Am J Med Sci 257: 415–419

    Article  PubMed  CAS  Google Scholar 

  • Alford FP, Dudley F J, Chisholm DJ, Findlay DM (1979) Glucagon metabolism in normal subjects and in cirrhotic patients before and after portasystemic venous shunt surgery. Clin Endocrinol (Oxf) 11: 413–424

    Article  CAS  Google Scholar 

  • Ansorge S, Kaiser B, Senger U, Bohley P, Langner J, Kirschner H (1972) Metabolismus von Insulin und Glukagon: über die Heterogenität und zur Charakterisierung der Insulin und Glukagon abbauenden Enzymsysteme in Rattenleberzellfraktionen. Acta Biol Md Ger 28: 761–777

    CAS  Google Scholar 

  • Bhathena SJ, Voyles NR, Smith S, Recant L (1978) Decreased glucagon receptors in diabetic rat hepatocytes. Evidence for regulation of glucagon receptors by hyperglucagonemia. J Clin Invest 61: 1488–1497

    Article  PubMed  CAS  Google Scholar 

  • Bilheimer DW, Goldstein JL, Grundy SM, Brown MS (1975) Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia. J Clin Invest 56: 1420–1430

    Article  PubMed  CAS  Google Scholar 

  • Buchanan KD, Solomon SS, Vance JE, Porter HP, Williams RH (1968) Glucagon clearance by the isolated perfused rat liver. Proc Soc Exp Biol Med 128: 620–623

    PubMed  CAS  Google Scholar 

  • Conn HO, Daughaday WH (1970) Cirrhosis and diabetes. V. Serum human growth hormone levels in Laennec’s cirrhosis. J Lab Clin Med 76: 678–688

    PubMed  CAS  Google Scholar 

  • Creutzfeldt W, Frerichs H, Sickinger K (1970) Liver disease and diabetes mellitus. Prog Liver Dis 3: 371–407

    PubMed  CAS  Google Scholar 

  • Davies TF, Prudhoe K, Douglas AP (1976) Plasma cyclic adenosine-3′,5′-monophosphate response to glucagon in patients with liver disease. Br Med J 1: 931–933

    Article  PubMed  CAS  Google Scholar 

  • DeRubertis FR, Craven P (1976) Reduced sensitivity of the hepatic adenylate cyclase-cyclic AMP system to glucagon during sustained hormonal stimulation. J Clin Invest 57: 435–443

    Article  Google Scholar 

  • Doyle JA, Schroeter AL, Rogers RS III (1979) Hyperglucagonaemia and necrolytic migratory erythema in cirrhosis: possible pseudoglucagonoma syndrome. Br J Dermatol 100: 581–587

    Google Scholar 

  • Dudley F J, Alford FP, Chisholm DJ, Findlay DM (1979) Effect of portasystemic venous shunt surgery on hyperglucagonaemia in cirrhosis: paired studies of pre and post shunted subjects. Gut 20: 817–824

    Article  PubMed  CAS  Google Scholar 

  • Felber JP, Magnenat P, Vannoti A (1967) Tolérance au glucose diminuée et réponse insulinique élevée dans la cirrhose. Schweiz Med Wochensch 97: 1537–1539

    CAS  Google Scholar 

  • Franca villa A, Jones AF, Starzl TE (1978) Cyclic AMP metabolism and adenylate cyclase concentration in patients with advanced hepatic cirrhosis. Gastroenterology 75: 1026–1032

    Google Scholar 

  • Greco AV, Ghirlanda G, Patrono C, Fedeli G, Manna R (1974) Behavior of pancreatic glucagon, insulin and HGH in liver cirrhosis, after arginine and i. v. glucose. Acta Diabetol Lat 11: 330–339

    Article  PubMed  CAS  Google Scholar 

  • Greco AV, Crucitti F, Ghirlanda G, Manna R, Altomonte L, Rebuzzi AG, Bertoli A (1979 a) Insulin and glucagon concentrations in portal and peripheral veins in patients with hepatic cirrhosis. Diabetologia 17: 23–28

    Article  PubMed  CAS  Google Scholar 

  • Greco AY, Rebuzzi AG, Altomonte L, Manna R, Bertoli A, Ghirlanda G (1979 b) Glucose, insulin and somatostatin infusion for the determination of insulin resistance in liver cirrhosis. Horm Metab Res 11: 547–549

    Google Scholar 

  • Greco AY, Altomonte L, Ghirlanda G, Rebuzzi AG, Manna R, Bertoli A (1980) Somatostatin infusion in liver cirrhosis: glucagon control of glucose homeostasis. Diabetologia 18: 187–191

    Article  PubMed  CAS  Google Scholar 

  • Gurr J A, Ruh TA (1980) Desensitization of primary cultures of adult rat liver parenchymal cells to stimulation of adenosine 3′,5′-monophosphate production by glucagon and epinephrine. Endocrinology 107: 1309–1319

    Article  PubMed  CAS  Google Scholar 

  • Gutman RA, Fink G, Voyles N, Selawry H, Penhos JC, Lepp A, Recant L (1973) Specific biologic effects of intestinal glucagon like materials. J Clin Invest 52:1165–1175

    Google Scholar 

  • Harris V, Faloona GR, Unger RH (1979) Glucagon. In: Jaffe BM, Behrman HR (eds) Methods of hormone radioimmunoassay, 2nd edn. Academic Press, New York, p 643

    Google Scholar 

  • Hoist J J, Burcharth F, Kühl C (1980) Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal. Diabete Metab 6: 117–127

    Google Scholar 

  • Jaspan JB, Polonsky KS, Rojdmark S, Ishida T, Field JB, Rubenstein AH (1981) Hepatic extraction of plasma immunoreactive glucagon components: predilection for 3500 daltons glucagon metabolism by the liver. Diab 30: 767–772

    Article  CAS  Google Scholar 

  • Lickley HLA, Chisholm DJ, Rabinovitch A, Wexler M, Dupre J (1975) Effects of portacaval anastomosis on glucose tolerance in the dog: evidence of an interaction between the gut and the liver in oral glucose disposal. Metabolism 24: 1157–1168

    Article  PubMed  CAS  Google Scholar 

  • Maekubo H, Matsushima T, Okada F, Honma M, Ui M (1980) Anomalous plasma cyclic AMP responses to glucagon in patients with liver disease. Dig Dis Sci 25: 700–704

    Article  PubMed  CAS  Google Scholar 

  • Marchesini G, Forlani G, Angiolini A, Zoli M, Scolari MP, Bianchi FB, Pisi E (1979 a) Oral glucose in cirrhotics. Effects on plasma amino acid patterns and the role of insulin and glucagon. Diab Metab 5: 135–139

    Google Scholar 

  • Marchesini G, Forlani G, Zoli M, Angiolini A, Scolari MP, Bianchi FB, Pisi E (1979 b) Insulin and glucagon levels in liver cirrhosis. Relationship with plasma amino acid imbalance of chronic hepatic encephalopathy. Dig Dis Sci 24: 594–601

    Google Scholar 

  • Marco J, Calle C, Román D, Díaz-Fierros M, Villanueva ML, Valverde I (1973 a) Hyper glucagonism induced by glucocorticoid treatment in man. N Engl J Med 288: 128–131

    Google Scholar 

  • Marco J, Diego J, Villanueva ML, Díaz-Fierros M, Valverde I, Segovia JM (1973 b) Elevated plasma glucagon levels in cirrhosis of the liver. N Engl J Med 289: 1107–1111

    Google Scholar 

  • Marco J, Hedo J A, Villanueva ML, Calle C, Corujedo A, Segovia JM (1977) Effect of food ingestion on intestinal glucagon like immunoreactivity (GLI) secretion in normal and gastrectomized subjects. Diabetologia 13: 131–135

    Article  PubMed  CAS  Google Scholar 

  • McDonald TJ, Dupre J, Caussignac Y, Radziuk J, Van Vhiet S (1979) Hyperglucagonemia in liver cirrhosis with portal systemic venous anastomoses: responses of plasma glucagon and gastric inhibitory polypeptide to oral or intravenous glucose in cirrhotics with normal or elevated fasting plasma glucose levels. Metabolism 28: 300–307

    Article  PubMed  CAS  Google Scholar 

  • Müller WA, Faloona GR, Unger RH (1971) The effect of experimental insulin deficiency on glucagon secretion. J Clin Invest 50: 1992–1999

    Article  PubMed  Google Scholar 

  • Perez G, Trimarco B, Ungaro B, Rengo F, Sacca L (1978) Glucoregulatory response to insulin induced hypoglycemia in Laennec’s cirrhosis. J Clin Endocrinol Metab 46: 778–783

    Article  PubMed  CAS  Google Scholar 

  • Pías C, Nunez J (1975) Glycogenolytic response to glucagon of cultured fetal hepatocytes. J Biol Chem 250: 530–5311

    Google Scholar 

  • Podolsky S, Zimmerman HJ, Burrows BA, Cardarelli JA, Pattavina CG (1973) Potassium depletion in hepatic cirrhosis: a reversible cause of impaired growth–hormone and insulin response to stimulation. N Engl J Med 288: 644–648

    Article  PubMed  CAS  Google Scholar 

  • Popper H, Elias H, Petty DE (1952) Vascular pattern of the cirrhotic liver. Am J Clin Pathol 22: 717–729

    PubMed  CAS  Google Scholar 

  • Proietto J, Alford FP, Dudley FJ (1980) The mechanism of the carbohydrate intolerance of cirrhosis. J Clin Endocrinol Metab 51: 1030–1036

    Article  PubMed  CAS  Google Scholar 

  • Rudman D, Vogler WR, Howard CH, Gerron GG (1971) Observations on the plasma amino acids of patients with acute leukemia. Cancer Res 31: 1159–1165

    PubMed  CAS  Google Scholar 

  • Sherwin R, Joshi P, Hendler R, Felig P, Conn HO (1974) Hyperglucagonemia in Laennec’s cirrhosis. The role of portal systemic shunting. N Engl J Med 290: 239–242

    Article  PubMed  CAS  Google Scholar 

  • Sherwin RS, Fisher M, Bessoff J, Snyder N, Hendler R, Conn HO, Felig P (1978) Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon. Gastroenterology 74: 1224–1228

    PubMed  CAS  Google Scholar 

  • Shurberg JL, Resnick R, Koff RS, Ros E, Baum RA, Pallota JA (1977) Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis. Gastroenterology 72: 301–304

    PubMed  CAS  Google Scholar 

  • Smith–Laing G, Orskov H, Gore MBR, Sherlock S (1980) Hyperglucagonemia in cirrhosis. Diabetologia 19: 103–108

    Article  Google Scholar 

  • Soeters PB, Fischer JE (1976) Insulin, glucagon, aminoacid imbalance, and hepatic encephalopathy. Lancet 2: 880–882

    Article  PubMed  CAS  Google Scholar 

  • Soeters PB, Weir G, Ebeid AM, Fischer JE (1977) Insulin, glucagon, portal systemic shunting, and hepatic failure in the dog. J Surg Res 23: 183–188

    Article  PubMed  CAS  Google Scholar 

  • Strange RC, Mjos OD, Henden T, Jynge P (1977) The effect of glucagon on plasma cyclic AMP and glucose concentrations in patients with alcoholic cirrhosis. Acta Med Scand 202: 87–88

    Article  PubMed  CAS  Google Scholar 

  • Strombeck DR, Rogers Q, Stern JS (1978) Effects of intravenous ammonia infusion on plasma levels of amino acids, glucagon and insulin in dogs. Gastroenterology 74: 1165

    Google Scholar 

  • Unger RH (1968) New ideas concerning the physiologic roles of glucagon. Am J Med Sci 255: 273–276

    Article  PubMed  CAS  Google Scholar 

  • Valverde I, Villanueva ML (1976) Heterogeneity of plasma immunoreactive glucagon. Metabolism [Suppl] 1: 1393–1395

    Google Scholar 

  • Walker C, Peterson W, Unger R (1974) Blood ammonia levels in advanced cirrhosis during therapeutic elevation of the insulin: glucagon ratio. N Engl J Med 291: 168–171

    Article  PubMed  CAS  Google Scholar 

  • Weglicki WB, Ganda OP, Soeldner JS, Murawski BJ, Cohn LH, Couch NP (1977) Portacaval diversion for severe hypercholesterolemia. Report of a case with measurements of glucose tolerance, insulin and glucagon levels. Arch Surg 112: 634–636

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. J. Marco
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Liège, Boulevard de la Constitution, 66, 4020, Liège, Belgium

    Pierre J. Lefebvre M.D. (Professor of Medicine, Guest Professor, Corresponding Member, Chairman, Head) (Professor of Medicine, Guest Professor, Corresponding Member, Chairman, Head)

  2. University of Brussels (V.U.B.), Boulevard de la Constitution, 66, 4020, Liège, Belgium

    Pierre J. Lefebvre M.D. (Professor of Medicine, Guest Professor, Corresponding Member, Chairman, Head) (Professor of Medicine, Guest Professor, Corresponding Member, Chairman, Head)

  3. Royal Academy of Medicine of Belgium, Boulevard de la Constitution, 66, 4020, Liège, Belgium

    Pierre J. Lefebvre M.D. (Professor of Medicine, Guest Professor, Corresponding Member, Chairman, Head) (Professor of Medicine, Guest Professor, Corresponding Member, Chairman, Head)

  4. Medical Policlinics, University of Liège, Boulevard de la Constitution, 66, 4020, Liège, Belgium

    Pierre J. Lefebvre M.D. (Professor of Medicine, Guest Professor, Corresponding Member, Chairman, Head) (Professor of Medicine, Guest Professor, Corresponding Member, Chairman, Head)

  5. Division of Diabetes, University of Liège, Boulevard de la Constitution, 66, 4020, Liège, Belgium

    Pierre J. Lefebvre M.D. (Professor of Medicine, Guest Professor, Corresponding Member, Chairman, Head) (Professor of Medicine, Guest Professor, Corresponding Member, Chairman, Head)

  6. Institut de Médecine, Hôpital de Bavière, Boulevard de la Constitution, 66, 4020, Liège, Belgium

    Pierre J. Lefebvre M.D. (Professor of Medicine, Guest Professor, Corresponding Member, Chairman, Head) (Professor of Medicine, Guest Professor, Corresponding Member, Chairman, Head)

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Marco, J. (1983). Glucagon in Cirrhosis of the Liver. In: Lefebvre, P.J. (eds) Glucagon II. Handbook of Experimental Pharmacology, vol 66 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69019-8_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-69019-8_26

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-69021-1

  • Online ISBN: 978-3-642-69019-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation